Document is current
Any future updates will be listed below
-
Authors
Poddubnyy, Denis https://orcid.org/0000-0002-4537-6015
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Accepted: 5 March 2023
First Online: 28 March 2023
Declarations
:
: DP: research support from: AbbVie, Eli Lilly, MSD, Novartis, Pfizer; consulting fees from: AbbVie, Biocad, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Janssen, MSD, Moonlake, Novartis, Pfizer, Samsung Bioepis, and UCB; speaker fees from: AbbVie, Bristol-Myers Squibb, Eli Lilly, Janssen, MSD, Medscape, Novartis, Peervoice, Pfizer, and UCB. Member of executive committee of ASAS. Member of steering committee of GRAPPA.
: Open Access funding enabled and organized by Projekt DEAL. This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DP is the sole author of this review.
